"Harnessing AI for treatment optimization : Neoadjuvant chemotherapy in gastroesophageal cancer"
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:50 |
|---|---|
| Enthalten in: |
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology - 50(2024), 4 vom: 29. Apr., Seite 108228 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sheen, Abdullah Rizwan [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
AI models |
|---|
| Anmerkungen: |
Date Completed 01.04.2024 Date Revised 01.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ejso.2024.108228 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369205812 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369205812 | ||
| 003 | DE-627 | ||
| 005 | 20240401232713.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240304s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ejso.2024.108228 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1359.xml |
| 035 | |a (DE-627)NLM369205812 | ||
| 035 | |a (NLM)38430705 | ||
| 035 | |a (PII)S0748-7983(24)00280-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sheen, Abdullah Rizwan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a "Harnessing AI for treatment optimization |b Neoadjuvant chemotherapy in gastroesophageal cancer" |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.04.2024 | ||
| 500 | |a Date Revised 01.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a AI models | |
| 650 | 4 | |a Cancer management | |
| 650 | 4 | |a Gastroesophageal cancer | |
| 650 | 4 | |a Morbidity | |
| 650 | 4 | |a Mortality | |
| 650 | 4 | |a Neoadjuvant chemotherapy | |
| 700 | 1 | |a Saqib, Hasnain Wajeeh Us |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology |d 1993 |g 50(2024), 4 vom: 29. Apr., Seite 108228 |w (DE-627)NLM01262862X |x 1532-2157 |7 nnns |
| 773 | 1 | 8 | |g volume:50 |g year:2024 |g number:4 |g day:29 |g month:04 |g pages:108228 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ejso.2024.108228 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 50 |j 2024 |e 4 |b 29 |c 04 |h 108228 | ||